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Affiliation to Alcoholics Anonymous or Narcotics Anonymous among patients attending an 
English specialist addiction service 
 
Abstract 
Purpose 
Attendance at Alcoholics Anonymous (AA) or Narcotics Anonymous (NA) meetings and affiliation 
with the Fellowship has potential benefits for people with alcohol or drug use disorders. This effect 
is present whether or not the individual attends professional treatment services, but the two 
process can have a synergistic effect. Limited information exists about the extent to which people 
attending UK specialist treatment services also attend AA/NA and their views about such 
attendance. 
Design/methodology/approach 
A cross-sectional survey of 200 consecutive attendees at the specialist treatment service in an 
English region was conducted between January and April 2018. A measure of past attendance and 
affiliation with AA/NA (AAAS) and a scale designed to quantify future readiness to attend (SYRAAP) 
were administered and anonymously linked to data supplied to the National Drug Treatment 
Monitoring Service (NDTMS).  
Findings 
A minority of the sample had ever attended an AA meeting (31%, n= 59) or an NA meeting (41%, 
n=79), and only 14% (n=27) and 24% (n=45) had attended an AA or NA meeting respectively in the 
past year. Only two variables significantly predicted level of readiness to attend AA or NA in a 
regression model: attended more AA/NA meetings in the past (β=0.149, p=0.036) and previous level 
of participation (AAAS score) (β=0.409, p<0.001). 
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Practical implications 
A significant proportion of attendees of a specialist drug and alcohol treatment service had never 
attended AA/NA, despite many positive views about their potential benefits. Given the established 
benefits of attending AA/NA meetings and participating in the AA or NA Fellowship, these results 
suggest that professional treatment services should do more to explain the process and challenge 
pre-conceived ideas about how they operate. 
Originality/value 
The authors are not aware of any published research that captures the rates of attendance of and 
participation in both AA and NA groups in a UK-based community treatment sample. These results 
may therefore provide a baseline for evaluating the impact of interventions to increase 
attendance/participation, and also provide some insight into the potential barriers to attendance in 
this population. 
Keywords 
Self-help groups; Alcoholics Anonymous; Narcotics Anonymous, Addiction Treatment; Attitudes; 
Affiliation 
Paper type – research paper 
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Introduction 
Rates of abstinence from alcohol among individuals who attend Alcoholics Anonymous (AA) are 
more than double that of non-attenders, with evidence of a dose-response effect (Kaskutas, 2009). 
Encouraging 12-Step mutual self-help group (TSG) attendance significantly reduces healthcare 
utilisation costs (Humphreys and Moos, 2001, Humphreys et al., 2004), and participation in AA after 
professional treatment is associated with reduced drinking and fewer psychosocial problems (Emrick 
et al., 1993, Humphreys and Noke, 1997, Tonigan et al., 1996). Less is known about Narcotics 
Anonymous (NA), but length of time in NA has been found to be related to abstinence from illicit 
drugs (Christo and Franey, 1995), and involvement with NA after treatment is associated with the 
development of social networks that are more supportive of abstinence (Humphreys and Noke, 
1997). 
Combined professional and peer-support recovery is associated with better long-term outcomes 
than either approach alone (Dawson et al., 2006), and attempts to systematically engage people 
with substance use disorders in TSGs have yielded positive outcomes (Manning et al., 2012, Timko 
and DeBenedetti, 2007). However, the limited evidence base from the UK suggests that relatively 
few substance users attend them, and any attendance is short-lived (Day et al., 2005, Gossop et al., 
2007, Gaston et al., 2010). The English National Drug Treatment Monitoring Service (NDTMS) 
requires treatment services to report activity in delivering two intervention strategies related to 
TSGs. The first is called ‘12-step work’ and is defined as ‘a 12-step intervention for recovery from 
addiction, compulsion or other behavioural problems’, where the aim is ‘to facilitate service users to 
complete some or all of the 12 steps’. This intervention was initially developed for Project MATCH 
(Nowinski et al., 1999), and later adapted for patients with drug use disorders (Baker, 1998). The 
second, ‘facilitated access to mutual aid’, is defined as the process where ‘staff provide a service user 
with information about mutual aid groups and facilitate their initial contact by, for example, making 
arrangements for them to meet a group member, arranging transport and/or accompaniment to the 
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first session and dealing with any subsequent concerns’. These groups may be based on 12-step 
principles or another approach (such as SMART Recovery). This intervention has been particularly 
influenced by the work of Timko and colleagues (Timko and DeBenedetti, 2007). Activity in delivering 
either of these interventions is reported every three months for all patients. Of the 262,109 
individuals who had received treatment from specialist services for drug or alcohol use disorders by 
the final quarter of 2017-18, 4% (10,874) had received a ‘12-step work’ intervention, and 24% 
(63,256) had received a ‘facilitated access to mutual aid’ intervention. The latter is likely to 
overestimate referral to TSGs specifically, as the reporting criteria refer to any mutual aid group. 
Professional treatment staff in England are ambivalent about encouraging their patients to attend, 
and often have low levels of knowledge about TSGs (Day et al., 2005, Wall et al., 2014). However, 
‘facilitated access’ interventions have been shown to be associated with more meeting attendance 
during follow-up than merely recommending attendance among patients with limited previous 12-
Step meeting attendance (Manning et al., 2012, Timko and DeBenedetti, 2007). The UK treatment 
population may therefore benefit from better linkage between professional and peer-led groups. 
There has been a growth in interest in TSGs in the UK in the past 10 years (Public Health England, 
2013). However, there is very little published UK-based research data to quantify the level of TSG 
attendance amongst treatment populations (see table 4). The National Treatment Outcome 
Research Study (NTORS) explored TSG attendance in a subsample of drug users treated in residential 
settings (Gossop et al., 2007).  During the 2 years prior to treatment, 35% (50/142) of the sample 
attended at least one NA or AA meeting, and among those who attended NA/AA the mean number 
of meetings attended was 26.6. NA attendance was more common than AA attendance (28% versus 
16%). Patients who attended NA or AA after treatment were more likely to be abstinent from 
opiates at follow-up, but no additional benefit was found for NA/AA attendance in stimulant users. 
More frequent NA/AA attenders were more likely to be abstinent from opiates and alcohol when 
compared both to non-attenders and to infrequent (less than weekly) attenders.  
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Three separate projects explored TSG attendance amongst patients at two specialist inpatient units 
in south London. Best et al. surveyed 200 inpatients, half of which had a primary alcohol problem 
and half a primary drug problem (Best et al., 2001). Over three-quarters (77%, n=154) had attended 
a 12-step meeting in the past, and 51% had done so in the past year (n=102). Gossop et al. 
interviewed 150 admissions with primary alcohol problems and followed them up over 6 months 
post-discharge (Gossop et al., 2003, Harris et al., 2003). Again, three-quarters had added an AA 
meeting in their lifetime (73%, n=110), but only 41% (n=61) in the year prior to admission.  Finally, a 
randomised controlled trial of methods to facilitate attendance at TSG meetings conducted in an 
inpatient unit reported that 108 of 151 (72%)  participants (primary problem = 57% alcohol, 43% 
drugs) had ever attended an AA/NA meeting, and 38% (n=57) in the past year (Manning et al., 2012). 
London has traditionally had a high level of weekly TSG meetings, but a similar study with a mixed 
drug/alcohol dependent population at a specialist inpatient unit in Birmingham found similar results 
(69% ever attended, 33% in the preceding year (Gaston et al., 2010). Research has therefore 
focussed on treatment populations in specialist residential settings, where the treatment goal has 
usually been abstinence. There is no equivalent research in the UK focussing on community 
treatment settings, and in particular opioid dependent individuals receiving opioid agonist treatment 
(OAT). Data from the USA indicate that levels of AA/NA attendance and affiliation in this population 
are lower than in residential settings where patients are often actively encouraged to participate in 
TSGs (Humphreys et al., 1998).  
This project aimed to explore past attendance and participation in TSG meetings in patients 
attending a community substance use treatment service, and their potential readiness for future 
participation. We wanted to measure the level of acceptability of TSGs to current patients of the 
service, and compare those with a primary alcohol problem to those with a primary illicit drug 
problem. By linking data on TSG participation/future intentions to routinely-collected demographic 
and substance use data we also aimed to highlight possible ways of targeting interventions to 
patients.  
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Methods 
Setting  
A survey was conducted of patients receiving treatment for alcohol or drug problems within a single 
metropolitan borough in the English West Midlands with a population of approximately 250,000 in 
urban, suburban and rural locations. The treatment service was provided by the National Health 
Service (NHS) in partnership with three local not-for-profit agencies and commissioned to provide 
specialist community services for alcohol and drug (opiate and non-opiate) problems for people of 
all ages living within the borough. It had a caseload of 1200 active patients at the time of the survey.  
Participants 
The eligibility criteria were: (1) attending a routine appointment at the service between April and 
June 2019; (2) able to read and understand English; (3) able and willing to complete a questionnaire 
taking approximately 10 minutes; (4) aged 18 years or above. 
Procedure 
Sequential patients attending the service for a routine appointment were approached by staff over a 
12-week period in order to survey 200 patients. Participation was voluntary, and refusal to 
participate did not have any impact on the treatment received from the service. The keyworker 
asked the patient to complete the questionnaire, and the patient was given a £5 shopping voucher 
in recognition of their time.  
No personal information that would identify the patient was added to the questionnaire (name, date 
of birth, address), but the keyworker added the client’s unique service number. This was then linked 
to data routinely collected for the National Drug Treatment Monitoring System (NDTMS) through the 
service number, thus avoiding any patient-identifiable data being included. Patients give consent for 
this data to be analysed anonymously as part of service evaluation, and if this consent was not 
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received the data was not included. The study was approved as a Service Evaluation project by the 
NHS Trust Research & Innovation Department. 
Measures 
Self-administered survey measures have been developed to assess both previous participation in 
AA/NA-related activities and future intentions to participate (e.g. (Humphreys et al., 1998, Kingree et 
al., 2007). Past research has examined a wide range of demographic, personality, social, cognitive, 
and substance-related variables as potential predictors of AA participation. Reviews of this research 
have indicated alcohol problem severity is the most reliable predictor (Emrick et al., 1993, Tonigan et 
al., 1996), but other variables have been less promising (Emrick et al., 1993, McKay et al., 1998, 
Morgenstern et al., 1998). Two measures with established reliability and validity in treatment 
populations were therefore used:  
1. The AA Affiliation Scale (AAAS) is a 9-item scale covering a range of AA experiences (Humphreys et 
al., 1998). Questions 1 to 7 cover examples of participation in AA activities, and questions 8 and 9 
capture the number of meetings attended by the respondent in their lifetime and the past 12 
months respectively. The scale is internally consistent across diverse demographic groups in multiple 
health service settings, with psychometric norms established in a large, diverse, representative 
sample of treatment and non-treatment seeking individuals.  
2. The Survey of Readiness for Alcoholics Anonymous Participation (SYRAAP) is a brief, 
multidimensional, self-administered instrument that assesses beliefs associated with AA 
participation (Kingree et al., 2006). Based on the health belief model, it includes 15 items comprising 
three 5-item subscales: perceived severity of substance use, perceived benefits of AA participation, 
and perceived barriers to participation. Responses are made on a 5-point Likert-type scale, with 
options ranging from (1) “strongly disagree” to (5) “strongly agree”. The measure has shown strong 
internal reliability and validity, and has been shown to predict TSG affiliation better than any 
demographic or life context factor in North American treatment populations (Kingree et al., 2007). 
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Both measures were adapted to include questions about NA in addition to AA. Data were linked to 
NDTMS data including age, gender, ethnic group, primary problem substance, length of time in 
treatment, and 5 measures from the latest Treatment Outcome Profile (TOP) (Marsden et al., 2008):  
days used primary substance, days of paid work, psychological health score, physical health score 
and quality of life score. The TOP is administered every 3 months in clinical practice and assesses 
function over the preceding 30 days. 
Statistical analysis 
The first stage of the analysis was to describe the levels of TSG attendance and affiliation in the 
community sample and compare them with other published UK samples. We were also interested in 
measuring the level of acceptability of TSGs to the participants using the three components of the 
SYRAAP scale (perceived problem severity, benefits of attending TSG meetings, and barriers to TSG 
attendance). Secondly the sub-sample with primary alcohol problems was compared to those with 
primary illicit drug problems. Finally bivariate associations between the predictor variables and the 
SYRAAP sub-scales were examined. Pearson correlations examined associations between two 
continuously coded variables (e.g. SYRAAP severity and age) and independent groups t tests 
evaluated associations between one dichotomously-coded variable and one continuously-coded 
variable (e.g. SYRAAP severity and gender). Linear regression analysis was used to test the 
independent contributions of factors associated with the SYRAAP composite total (with the barriers 
sub-scale reverse coded). 
Results 
Sample characteristics 
The 200 questionnaires were distributed to consecutive attendees (5 patients declined to 
participate), and 191 were available for analysis (2 patients completed the questionnaire twice, and 
7 either failed to complete the full questionnaire or a failure to include the unique service number 
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prevented linkage to NDTMS data). Of the 191 participants, 73% (138) were male and 172 (90%) 
were of white British ethnicity. The mean age was 40.1 years (range 19 to 73), and 41 (21%) were in 
the first 3 months of treatment, 45 (24%) had been in treatment for between 3 months and 12 
months, and the remaining 105 (55%) had been in treatment for over 12 months. According to the 
NDTMS classification, 35% (n=67) reported a primary alcohol problem and 65% (n=124) reported a 
primary drug problem. When the sample was compared with NDTMS data for the whole service, 
there were no differences in mean age, sex distribution, or ethnicity.  
Attendance and participation in AA or NA meetings 
A minority of the sample had ever attended an AA meeting (31%, n= 59) or an NA meeting (41%, 
n=78). In the past year 27 (14%) participants had attended an AA meeting and 45 (24%) had 
attended an NA meeting. In total 92 (48%) of the participants had ever been to either an AA or an 
NA meeting, and 52 (27%) had been to either meeting in the past year. Of those who had attended 
at least one AA or NA meeting, the median number of meetings ever attended and the median 
number attended in the past year are shown in table 1. Only 4 participants had attended 50 or more 
(i.e. weekly) meetings in the past year. Table 2 summarises the responses to individual items of the 
SYRAAP questionnaire. 
Comparison between primary alcohol and primary drug users 
Table 1 shows a comparison between the group with primary alcohol problems (n=67) and those 
with primary drug problems (n=124). There were no statistically significant differences between the 
group with alcohol problems and the drug-using group in their responses to individual items of the 
SYRAAP instrument. 
Possible predictors of AA or NA attendance 
Bivariate associations between potential predictors of AA or NA attendance and the SYRAAP 
subscales are shown in table 3. There was a significant correlation between previous attendance and 
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involvement in TSGs and all three SYRAAP sub-scales, although the level of correlation was lower for 
the (reversed) barriers sub-scale than the others. There was a significant correlation between TOP 
psychological health, physical health and quality of life scores and the SYRAAP severity scale 
(negative correlation, i.e. the better the reported health, the lower the severity) and the SYRAAP 
(reversed) barriers scale (positive correlation i.e. the better the reported health, the less perceived 
barriers to attendance at TSGs). However, there was no correlation between health/quality of life 
and SYRAAP beliefs. The number of days of substance use in the past 30 was significantly negatively 
correlated with all three health/quality of life measures and the reversed SYRAAP Barriers subscale, 
suggesting more current use was associated with worse health and more barriers to TSG attendance. 
A linear regression model was then used to examine the simultaneous effects of the best predictor 
variables available from previous research (AAAS ‘participation’ score, number of TSG meetings 
attended in lifetime, age, length of time in treatment, gender, alcohol or drug problems, days used 
primary drug in the past 30, and quality of life) and the SYRAAP composite total (with the barriers 
sub-scale reverse coded). A total of 187 cases were analysed and the full model was significantly 
reliable (F = 8.698, d.f. = 7, p<0.001) with a model fit of R2 = 0.25. Only two variables significantly 
predicted SYRAAP score in the final model: attended more TSG meetings in the past (β=0.149, 
p=0.036) and AAAS participation score (β=0.409, p<0.001). 
 
Discussion 
Just under half of nearly 200 consecutive attenders at an English specialist drug and alcohol service 
had ever attended an AA or NA meeting, and just over a quarter had attended in the past year. 
Those with a primary drug problem were more likely to have ever attended, but those with a 
primary alcohol problem were more likely to have attended in the past year. Current data suggest 
that very few English community services offer treatment interventions that incorporate the 12 
steps, and this is not surprising. Traditionally residential services offered the bulk of the abstinence-
11 
 
focussed treatment, particularly those utilising the Minnesota Model (Leighton and Barton, 2005). 
Strong links were often formed with local TSGs, and NA in particular (Leighton, 2012). However, 
despite the established benefits of attending TSG meetings and participating in a 12-step Fellowship 
(Humphreys et al., 2004), less than 25% of patients nationally received an intervention with the goal 
of linking them to TSGs in 2017-18. Best-practice guidance and evidence-based systematic reviews 
both advocate professional linkage to TSGs (Clinical Guidelines on Drug Misuse and Dependence 
Update 2017 Independent Expert Working Group, 2017, National Collaborating Centre for Mental 
Health, 2008), and so the low rates of activity reported to NDTMS are surprising and disappointing. 
NDTMS data about treatment interventions are not verified independently, but in the competitive 
world of treatment provision in England services are more likely to over-estimate the number of 
interventions delivered than under-estimate. Therefore, what are the possible barriers to TSG 
referral and attendance, and what are the potential solutions to increase such linkage? 
Barriers to TSG referral and attendance 
One barrier is an objection to elements of the 12-step programme. Many of the core features 
(spiritual awakening, powerlessness over substances, and the need to surrender) go against the 
dominant western cultural norms of self-reliance and widespread secularism (Laudet, 2000, Laudet, 
2003), and UK treatment staff report that these elements are major obstacles to recommending NA 
attendance (Day et al., 2015). In a Norwegian treatment sample, Vederhus et al. found that 
embarrassment at attending AA/NA (37%) and not wanting other people to know that s/he was 
going to AA/NA (29%) were the most frequently cited barriers (Vederhus et al., 2011). 
SYRAAP data from the present study suggests that patients see the impact of drink or drugs on their 
interpersonal relationships, and recognise the potential benefits of a Fellowship in helping them. The 
whole sample was more likely to agree than disagree with positive statements about TSGs and 
demonstrated an awareness that they may meet positive people and find people who understood 
them there. In terms of potential barriers to attending, less than a third felt that TSG attendance 
12 
 
would be embarrassing (31.4%), depressing (18.9%) or require changes that were too difficult 
(24.1%). However, a majority (56.1%) still endorsed the statement ‘I feel I do not belong at AA or NA 
meetings’. 
It is also significant that the study sample had twice as many participants with primary drug 
problems than alcohol problems, and over half (57%) were receiving a prescription for opioid agonist 
treatment (OAT). The expectation that patients are encouraged to attend TSGs is based on the 
assumption that abstinence is their primary goal. However, there is evidence that this is not always 
the case in people with opioid dependence. For example, only 61% of a study population receiving 
OAT in specialist treatment services in the English West Midlands reported a goal of being abstinent 
from all opioids within 12 months (Day et al., 2018). It is not clear that NA participation is an 
effective strategy in helping people to move from OAT to abstinent recovery, and OAT programmes 
and 12-step programmes have been considered incompatible (Ronel et al., 2011). The 12-Step 
philosophy of complete abstinence is ‘rooted in the collective experience of its members that all past 
attempts that fell short of complete abstinence ended in pain and tragedy.’ Taking prescribed 
methadone or buprenorphine may be considered ‘a continued effort at control rather than 
surrender’, and restrictions placed on OAT patients when attending TSGs (e.g. the right to claim 
‘‘clean time’’, speak at meetings, sponsor others or hold service positions) (Day et al., 2015, White, 
2011, White et al., 2013). Therefore, it may be inappropriate to expect this population to participate 
regularly in TSGs. 
The figures for TSG attendance in the current study are lower than previous estimates in English 
treatment populations (approximately 75% ever attended and 33-58% in the past year, see table 4). 
However, previous studies involved patients of residential treatment services (see table 4), and 
previous work has shown greater AA/NA involvement amongst patients in residential settings than 
community settings (Humphreys et al., 1998), perhaps because there is a greater focus on 
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abstinence. The overall mean AAAS score in this study (1.71) was lower than both residential (3.48) 
and outpatient (2.16) scores in US samples (Humphreys et al., 1998). 
Possible solutions 
One possible answer is to create and promote mutual aid groups that provide an alternative to TSGs, 
but research on the nature and effectiveness of such alternatives is limited. Zemore et al. identify 
three mutual aid organisations as being the most active and well-used alternatives to AA/NA: 
Women for Sobriety (WFS), LifeRing Secular Recovery (LifeRing), and SMART Recovery (Self-
Management and Recovery Training, or SMART) (Zemore et al., 2018). Unfortunately, only one of 
these has a significant presence in the UK: there were seven weekly SMART meetings held within a 
10-mile radius of the treatment centre under investigation, but no LifeRing or Women for Sobriety 
groups (compared to 22 NA and 71 AA meetings). However, there is definitely a place for 
alternatives to TSGs and efforts to boost SMART and other approaches should be supported. 
A second option is to provide education for professional staff about TSGs. Increased staff knowledge 
is associated with the likelihood of recommending TSG attendance to patients (Wall et al., 2014), 
and so an on-going process of education about AA/NA is important in all professional services. Such 
efforts can improve knowledge/attitudes and change practice, but these initiatives tend to have a 
short-lived impact (Best et al., 2016). It is likely that a broader approach encompassing efforts to 
change staff knowledge, changes to staff-patient interactions, and broader organisational change is 
required to bring about large increases in TSG attendance in treatment populations (Day et al., 
2015).  
Study Limitations 
The limitations of this study mean that the results should be interpreted cautiously. Firstly, it was 
conducted at a single treatment service using a convenience sample, and so cannot be said to be 
representative of all patients accessing specialist treatment. The history of AA and NA in the UK 
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suggests that its uptake has varied indifferent areas, and a search for a local meeting on the UK AA 
or NA websites in different geographical areas produces a variable number of meetings with a 10- 
mile radius. Secondly, the measures were self-reported, and there were no objective measures of 
behaviour (e.g. meeting attendance).  
Another limitation was the cross-sectional nature of the study, and the UK lacks high quality long-
term (5 years plus) cohort studies of treatment populations that measure the impact of 
interventions. Best and colleagues have begun to describe theoretical models that underpin the 
transition from addiction to recovery, and two of the most widely researched areas are changes in 
social networks and changes in identity (Best et al., 2018). Increasing positive social connections, 
particularly with positive and supportive people that reinforce a social identity in recovery, appears 
to be an important process. The recovery-focused agenda that UK treatment services are now 
following demands greater attention to underpinning theoretical models and their use in guiding 
effective treatment interventions over time.
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Table 1. Comparison between the sub-sample with primary alcohol problems and the sub-sample with primary drug 
problems 
 ALCOHOL 
(n=67) 
DRUGS 
(n=124) 
Whole 
sample 
(n=191) 
 
Mean age 43.1 38.5 40.1 F=12.225 
p=0.001 
Male (%) 42 (63%) 97 (78%) 139 (73%) Χ2=5.301 
p=0.021 
Ethnicity = white British (%) 63 (94%) 109 (88%) 162 (85%) n.s. 
TOP Days used primary substance (out of 28) 11.2 (0-28) 8.2 (0-28) 9.3 (0-28) n.s 
TOP Days paid work (out of 28) 6.8 (0-28) 3.4 (0-24) 4.6 (0-28) F=7.493 
p=0.007 
TOP Psychological (1-20) 12.3 (2-20) 13.4 (4-19) 13.0 (2-20) n.s 
TOP Physical (1-20) 13.3 (2-20) 13.2 (5-20) 13.2 (2-20) n.s. 
TOP QoL (1-20) 13.3 (3-20) 13.6 (2-20) 13.5 (2-20) n.s. 
Of those who had attended a meeting: 
How many AA meetings would you estimate that you have gone 
to during your life? Median (Interquartile range, IQR) 
6 (21.5) 
N=25 
6.5 (27.3) 
N=34 
6 (27) 
N=59 
n.s. 
How many NA meetings would you estimate that you have gone 
to during your life? Median (IQR) 
19 (14) 
N=20 
12.5 (52.3) 
N=58 
16.5 (46) 
N=78 
n.s. 
How many AA meetings have you been to in the last 12 months? 
Median (IQR) 
4.0 (14.3) 
N=16 
3 (4) 
N=11 
4 (7) 
N=27 
n.s. 
How many NA meetings have you been to in the last 12 months? 
Median (IQR) 
6 (17) 
N=15 
4 (11) 
N=30 
4 (13) 
N=45 
n.s. 
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Table 2. Summary of the responses to the individual items of the Survey of Readiness for Alcoholics Anonymous 
Participation (SYRAAP) questionnaire.  
n=191 Strongly 
disagree/ 
disagree 
Neither 
disagree 
or agree 
Strongly 
agree/ 
agree 
SYRAAP Severity    
1. My alcohol or substance abuse problem is serious 29.4% 12.5% 58.1% 
6. My friendships have suffered as a result of my use of 
alcohol/substances 
18.4% 12.5% 69.1% 
7. I have been hurt financially by the use of alcohol and substances 13.0% 8.0% 79.0% 
11. My alcohol or substance use has hurt some other people 6.8% 10.3% 82.9% 
12. Using alcohol or substances has interfered with my ability to deal with 
everyday problems 
35.6% 37.2% 27.2% 
SYRAAP Beliefs    
2. If I go to AA or NA, I will find people who can guide me in how to be 
sober/clean 
18.4% 27.7% 53.9% 
4. I will feel better about myself if I go to AA or NA 17.8% 41.9% 40.3% 
9. I know someone who has been helped by going to AA or NA meetings 18.3% 25.6% 56.1% 
10. Going to AA or NA gives me courage to change 9.9% 46.1% 44.0% 
14. In AA or NA I will find people who understand me 7.4% 34.4% 58.2% 
SYRAAP Barriers    
3. Going to AA or NA can be embarrassing to me 40.8% 27.8% 31.4% 
5. Going to AA or NA makes me feel depressed  39.8% 41.3% 18.9% 
8. I feel I do not belong at AA or NA meetings 18.3% 25.6% 56.1% 
13. I do not want people to know I am going to AA or NA 35.6% 27.2% 27.2% 
15. Going to AA or NA requires changes that are too difficult 34.6% 41.3% 24.1% 
 
Note: The two positive responses (‘strongly agree’ and ‘agree’) and the two negative responses (‘disagree’ and 
‘strongly disagree’) have been collapsed into one category to simplify the presentation. 
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Table 3. Bivariate associations between potential predictors of AA or NA attendance and the SYRAAP subscales 
Table 3 AAAS No 
meetings 
ever 
attended 
AAAS 
lite 
Age Gender Time in 
Rx 
Drugs v 
Alcohol 
Days of 
use of 
primary 
substance 
Days 
work 
TOP 
Psych 
TOP 
Phys 
TOP 
QoL 
SYRAAP 
Total 
SYRAAP 
Severity 
SYRAAP 
Beliefs 
SYRAAP 
Barriers 
AAAS total                 
Number of TSGs 
ever attended 
.47a**                
AAAS lite .99a** .43a**               
Age -.15a .03a .03a              
Gender (male vs 
female) 
-1.20b -2.42b* -1.16b 1.43b             
Length of time in 
treatment 
0.57b -0.00b 0.75b -2.29b* 1.37b            
Drugs vs Alcohol 0.51b -0.74b 0.63b 4.40b** 4.36b* 30.18b*
* 
          
Days of use of 
primary substance 
-.11a .04a -.10a .14a -1.54b 1.77b 1.96b          
Days work -.04a -.10a -.03a .04a -1.23b 1.73b 2.56b* .01a         
TOP Psychological .07a -.03a .06a .03a .84a -2.09b* -1.33b -.39a* .15a*        
TOP Physical -.08a -.06a .07a -.06a .45a .85a .15a -.29a** .23a** .66a**       
TOP Quality of life -.02a -.09a -.02a .02a 1.04b -1.82b -.13a -.45a** .21a** .79a** .66a**      
SYRAAP Total .49a** .20a** .47a** .09a -1.09b -1.08b .82a -.07a .03a .08a -.03a -.03a     
SYRAAP Severity .32a** .16a* .32a** .07a 1.14b 1.69b -.07a .08a -.03a -.15a* -.18a* -.25a** .72a**    
SYRAAP Beliefs .46a** .19a** .45a** .07a 0.92b 1.14b 1.13b -.06a .00a .04a -.01a -.02a .85a** .47a**   
SYRAAP Barriers‡ .26a** .08a .25a** .06a 0.25b .65a 1.05b -.20a** .10a .30a** .15a* .23a** .59a** .01a .35a**  
 
a= Pearson correlation, b=t test 
*= p<0.05, **= p<0.005 
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Table 4. Summary of UK research into levels of attendance of and participation in TSGs, including the current study 
 
 
Solihull, whole sample 2018 
(n=191) 
London IPU 
(Manning et 
al., 2012) 
Birmingham 
IPU 2005 
(Gaston et al., 
2010) 
London IPU 
(Gossop et al., 
2003, Harris et 
al., 2003) 
London IPU (Best et al., 2001)  
(n=200) 
Type of sample Community Community Inpatient Inpatient Inpatient Inpatient Inpatient 
Primary substance 35% A  
(n=67) 
65% D 
(n=124) 
57% A 43% D 
(n=151) 
74% A 26% D 
(n=125) 
100% A 
(n=150) 
100% A  
(n=100) 
100% D  
(n=100) 
Mean age 43.1 38.5 39.9 39.8 42.2   
% male 63% 78% 67% 78% 74%   
Ever attended a 12-step meeting 27 (40%) 65 (52%) 108 (72%) 84 (69%) 110 (73%) 77 (77%) 77 (77%) 
Attended a 12-step meeting in the past year 19 (28%) 33 (27%)  57 (38%) 41 (33%) 61 (41%) 45 (45%) 58 (58%) 
Attended first 12-step meeting in the past year 17 (18%)   26 (17%)   
AA Affiliation Scale (AAAS)        
Ever considered yourself a member of AA or NA 22 (33%) 44 (36%)  6 (5%) 22 (15%) 17 (17%) 22 (22%) 
Ever called an AA or NA member for help 20 (30%) 34 (27%)      
Do you have an AA or NA sponsor at the moment 4 (6%) 7 (6%)      
Have you ever sponsored anyone in AA or NA 0 7 (6%)  2 (2%)  1 (1%) 3 (3%) 
Ever had a spiritual awakening or conversion experience 
through your involvement with AA or NA 
11 (16%) 21 (17%)   3 (2%) 2 (2%) 12 (12%) 
In past 12 months have you read any AA or NA literature 27 (40%) 46 (37%)      
In past 12 months have you done service (helped newcomers, 
set up chairs, made coffee, cleaned up after meeting) 
14 (21%) 15 (12%)      
Additional items from AA Involvement Scale (AAIS)        
Ever attended 90 meetings in 90 days     7 (5%) 5 (5%) 12 (12%) 
Ever celebrated a sobriety birthday    2 (2%)  7 (7%) 7 (7%) 
Ever worked a step     17 (11%) 6 (6%) 12 (12%) 
Ever had a sponsor     8 (5%) 12 (12%) 11 (11%) 
Mean number of TSG meetings in lifetime (range)* 134.3 (1-2000) 153.6 (1-2000)  26.2    
Mean number of AA meetings in lifetime (range)* 70.2 (0-1000) 51.0 (0-1000)   45.3 (1-500) 52.7  
Mean number of NA meetings in lifetime (range)* 64.1 (0-100) 102.6 (0-1000)      
Mean number of TSG meetings in past 12 months (range)* 23.1 (2-150) 19.6 (1-300)  3.9  20.9 28.5 
Mean number of AA meetings in past 12 months (range)* 12.8 (0-100) 5.8 (0-150)   17.8   
Mean number of NA meetings in past 12 months (range)* 10.4 (0-50)  13.7 (0-150)      
Mean AAAS score (SD) 1.71 (2.1) 1.66 (2.0) 1.49 (1.8)     
*of those who had attended at least one AA or NA meeting 
 
